News
New study determines factors that can send flu patients to the ICU
January 24, 2019
Patients with the flu sent to the ICU had a more frequent history of sleep apnea, MI, and a BMI greater than 30 g/m2.
News
AAN publishes position statement on brain death
January 8, 2019
The association calls for uniform laws and policies regarding brain death, as well as continued research and public education.
News
Synthetic opioids drive spike in U.S. fatal drug overdoses
January 4, 2019
Spurned by physicians, more users seem to be turning to street drugs that contain fentanyl and similar substances.
News
Topical antibiotic decolonizes S. aureus in NICU infants
January 3, 2019
Application of the topical antibiotic mupirocin significantly prevented both primary and persistent S. aureus colonization of NICU infants.
News
FDA aims to boost safety of platelets for transfusion
December 20, 2018
The agency is seeking input on ways to decrease the risk of bacterial contamination in platelets stored for 5 and 7 days after collection.
News
ICU-acquired pneumonia mortality risk may be underestimated
December 6, 2018
Hospital-acquired pneumonia imposes a greater mortality toll at 30 days than ventilator-associated pneumonia.
News
No difference between PPI prophylaxis, placebo for GI bleeding
December 6, 2018
There was no significant difference in mortality between critically ill patients who received pantoprazole prophylaxis for gastrointestinal bleeding, and those who received placebo.
News
ASH releases new VTE guidelines
November 28, 2018
A panel of the American Society of Hematology released more than 150 recommendations for dealing with venous thromboembolism.
News
Apixaban is safest effective DOAC for stroke prevention in Afib, per AHRQ report
November 10, 2018
The agency found the lowest bleeding risk with apixaban, but cites lack of head-to-head trials as a limitation in evaluating DOACs.
News
Lower glucose targets show improved mortality in cardiac patients
November 9, 2018
Lower blood glucose targets in critically ill cardiac patients are associated with lower 30-day mortality, compared with higher targets.